| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecb7d7f3a37cdebeffcaafcbab7bcb1e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate |
2020-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8a76b5e9e69ff461530d2bdb5a02b7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdebf3fc148cbec4c5fde273a28e45af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f21c3d2442a1094d40bee140323884f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d0a621b07d67eeb6593b85dbce7555b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d481d37a4ef39d55096fa3e8af915b64 |
| publicationDate |
2020-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020181232-A1 |
| titleOfInvention |
Heterocyclic compounds for medical treatment |
| abstract |
The present invention provides heterocyclic compounds that bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and their use for the treatment of abnormal cellular proliferation in a human or other host. The present invention also provides compounds that can be used as synthetic intermediates in the synthesis of bifunctional compounds used for targeted protein degradation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022235945-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023283372-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023283610-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023130054-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021061053-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114929670-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023283130-A1 |
| priorityDate |
2019-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |